The global Multiple Myeloma Market is undergoing dynamic transformation, propelled by rapid innovations in targeted biologics, immunotherapies, and combination drug regimens. As a malignant hematologic cancer characterized by abnormal proliferation of plasma cells in the bone marrow, multiple myeloma remains a primary focal point in oncology research and market investment. Market...